Professor David M Reid was awarded the iWantGreatCare certificate of excellence in 2024 for delivering outstanding care.
Reviews
Dr Reid managed to make the bad news he gave me manageable and understandable explaining everything in a friendly manner answering all my queries.
Prof D Reid sets a very high standard I wish all consultants were like. My poor mum has had severe osteoporosis diagnosed recently, a total shock to her, and not only did Prof Reid phone her that night to let her know in a kind manner, she then went in for an appointment and he spent the whole hour explaining what was wrong, what it meant and what she could do about it. He is a forward thinking, innovative consultant who has a lovely bedside manner and I too will be having a Dexa scan shortly with complete confidence in the service he offers. And if that's not enough, having digested all of the information we had been given by him, we phoned and contacted him for answers to our questions on top of our consultation, which he has been more than happy to answer. We feel very confident the right plan will be in place for mum. Brilliant!
Outstanding knowledge, care and advice.
Thank you
Professor Reid took the time to understand all of my background and to answer my many questions related to my bone density. He is clearly an expert in his field and I greatly appreciated having the benefit of this expertise.
All of this was done in a charming and personable manner.
Based on my first appointment with him Prof. Reid is not only an expert in his subject matter but also happy to answer questions and concerns and provide you with different options before making his recommendation.
He considers his patients holistically - which is essential.
Specialises in
- Rheumatology
Profile
Professor David Reid is Emeritus Professor of Rheumatology at the University of Aberdeen and was previous Head of the School of Medicine & Dentistry at the University.
He is a consultant rheumatologist and has been involved in providing specialist osteoporosis services with a particular emphasis on bone densitometry for 30 years. He therefore has a special interest in the use and interpretation of DXA or DEXA the main measurement tool.
He has over 300 original papers and reviews, largely on his research interests which include the utility of bone mass assessment, assessment of risk of fracture, secondary osteoporosis, glucocorticoid osteoporosis and the assessment of long-term disease activity and drug adverse effects in rheumatic diseases.
He was Chair of the Board of Trustees of the UK National Osteoporosis Society from 2008-2012 and has previously chaired their Research Grants Committee and Medical Board. Until late 2013 he was the Chair of the Arthritis Research UK Clinical Studies Group with responsibility for advising on the needs for clinical trials in bone diseases. He has been a member of numerous national committees most recently including the UK Medical Schools Council, the UK Health Education Advisory Committee and Scottish Stratified Medicine Innovation Centre Board.
He is now undertaking NHS locums in rheumatology and practicing privately in osteoporosis and acute rheumatology in London and Aberdeen. He is a great advocate for new and evolving therapies for osteoporosis.